1. Parity explains the age-associated increase in ANA prevalence in women ages 12 to 59 years, but not in those ages 60+.
Parity explains the age-associated increase in ANA prevalence in women ages 12 to 59 years, but not in those ages 60+. PORs were estimated by survey logistic regression for increasing decade of age; the trend test for age by ANA is shown. 1Estimates shown in the upper panel are adjusted for race/ethnicity and PIR. 2Estimates shown in the bottom panel are also adjusted for parity in women ages 12 to 59 years and parity plus age at menarche in women ages 60 years and older.
Christine G. Parks et al. Cancer Epidemiol Biomarkers Prev 2014;23:
©2014 by American Association for Cancer Research